Macrophages and platelets in liver fibrosis and hepatocellular carcinoma

During fibrosis, (myo)fibroblasts deposit large amounts of extracellular matrix proteins, thereby replacing healthy functional tissue. In liver fibrosis, this leads to the loss of hepatocyte function, portal hypertension, variceal bleeding, and increased susceptibility to infection. At an early stag...

Full description

Bibliographic Details
Main Authors: Martina Casari, Dominik Siegl, Carsten Deppermann, Detlef Schuppan
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1277808/full
_version_ 1827595601703862272
author Martina Casari
Dominik Siegl
Carsten Deppermann
Carsten Deppermann
Detlef Schuppan
Detlef Schuppan
Detlef Schuppan
author_facet Martina Casari
Dominik Siegl
Carsten Deppermann
Carsten Deppermann
Detlef Schuppan
Detlef Schuppan
Detlef Schuppan
author_sort Martina Casari
collection DOAJ
description During fibrosis, (myo)fibroblasts deposit large amounts of extracellular matrix proteins, thereby replacing healthy functional tissue. In liver fibrosis, this leads to the loss of hepatocyte function, portal hypertension, variceal bleeding, and increased susceptibility to infection. At an early stage, liver fibrosis is a dynamic and reversible process, however, from the cirrhotic stage, there is significant progression to hepatocellular carcinoma. Both liver-resident macrophages (Kupffer cells) and monocyte-derived macrophages are important drivers of fibrosis progression, but can also induce its regression once triggers of chronic inflammation are eliminated. In liver cancer, they are attracted to the tumor site to become tumor-associated macrophages (TAMs) polarized towards a M2- anti-inflammatory/tumor-promoting phenotype. Besides their role in thrombosis and hemostasis, platelets can also stimulate fibrosis and tumor development by secreting profibrogenic factors and regulating the innate immune response, e.g., by interacting with monocytes and macrophages. Here, we review recent literature on the role of macrophages and platelets and their interplay in liver fibrosis and hepatocellular carcinoma.
first_indexed 2024-03-09T02:55:52Z
format Article
id doaj.art-33a7d69edd854abfade7aaa448c73f3b
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-09T02:55:52Z
publishDate 2023-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-33a7d69edd854abfade7aaa448c73f3b2023-12-05T05:01:16ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-12-011410.3389/fimmu.2023.12778081277808Macrophages and platelets in liver fibrosis and hepatocellular carcinomaMartina Casari0Dominik Siegl1Carsten Deppermann2Carsten Deppermann3Detlef Schuppan4Detlef Schuppan5Detlef Schuppan6Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg-University, Mainz, GermanyInstitute for Translational Immunology, University Medical Center of the Johannes Gutenberg-University, Mainz, GermanyCenter for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg-University, Mainz, GermanyResearch Center for Immune Therapy Forschungszentrum für Immuntherapie (FZI), University Medical Center of the Johannes Gutenberg-University, Mainz, GermanyInstitute for Translational Immunology, University Medical Center of the Johannes Gutenberg-University, Mainz, GermanyResearch Center for Immune Therapy Forschungszentrum für Immuntherapie (FZI), University Medical Center of the Johannes Gutenberg-University, Mainz, GermanyDivision of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United StatesDuring fibrosis, (myo)fibroblasts deposit large amounts of extracellular matrix proteins, thereby replacing healthy functional tissue. In liver fibrosis, this leads to the loss of hepatocyte function, portal hypertension, variceal bleeding, and increased susceptibility to infection. At an early stage, liver fibrosis is a dynamic and reversible process, however, from the cirrhotic stage, there is significant progression to hepatocellular carcinoma. Both liver-resident macrophages (Kupffer cells) and monocyte-derived macrophages are important drivers of fibrosis progression, but can also induce its regression once triggers of chronic inflammation are eliminated. In liver cancer, they are attracted to the tumor site to become tumor-associated macrophages (TAMs) polarized towards a M2- anti-inflammatory/tumor-promoting phenotype. Besides their role in thrombosis and hemostasis, platelets can also stimulate fibrosis and tumor development by secreting profibrogenic factors and regulating the innate immune response, e.g., by interacting with monocytes and macrophages. Here, we review recent literature on the role of macrophages and platelets and their interplay in liver fibrosis and hepatocellular carcinoma.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1277808/fullangiogenesiscollagenendothelial cellKupffer cellMMPmonocyte
spellingShingle Martina Casari
Dominik Siegl
Carsten Deppermann
Carsten Deppermann
Detlef Schuppan
Detlef Schuppan
Detlef Schuppan
Macrophages and platelets in liver fibrosis and hepatocellular carcinoma
Frontiers in Immunology
angiogenesis
collagen
endothelial cell
Kupffer cell
MMP
monocyte
title Macrophages and platelets in liver fibrosis and hepatocellular carcinoma
title_full Macrophages and platelets in liver fibrosis and hepatocellular carcinoma
title_fullStr Macrophages and platelets in liver fibrosis and hepatocellular carcinoma
title_full_unstemmed Macrophages and platelets in liver fibrosis and hepatocellular carcinoma
title_short Macrophages and platelets in liver fibrosis and hepatocellular carcinoma
title_sort macrophages and platelets in liver fibrosis and hepatocellular carcinoma
topic angiogenesis
collagen
endothelial cell
Kupffer cell
MMP
monocyte
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1277808/full
work_keys_str_mv AT martinacasari macrophagesandplateletsinliverfibrosisandhepatocellularcarcinoma
AT dominiksiegl macrophagesandplateletsinliverfibrosisandhepatocellularcarcinoma
AT carstendeppermann macrophagesandplateletsinliverfibrosisandhepatocellularcarcinoma
AT carstendeppermann macrophagesandplateletsinliverfibrosisandhepatocellularcarcinoma
AT detlefschuppan macrophagesandplateletsinliverfibrosisandhepatocellularcarcinoma
AT detlefschuppan macrophagesandplateletsinliverfibrosisandhepatocellularcarcinoma
AT detlefschuppan macrophagesandplateletsinliverfibrosisandhepatocellularcarcinoma